F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients

Dimitrios Karantanis, Brian P. O'Neill, Rathan M. Subramaniam, Robert J. Witte, Brian P. Mullan, Mark A. Nathan, Val J. Lowe, Patrick J. Peller, Gregory A. Wiseman

Research output: Contribution to journalArticle

Abstract

To determine the value of F-FDG PET/CT in the different manifestations of primary central nervous system lymphoma (PCNSL) in HIV-negative patients.

Original languageEnglish (US)
Pages (from-to)834-841
Number of pages8
JournalNuclear medicine communications
Volume28
Issue number11
DOIs
StatePublished - Nov 2007

Keywords

  • PCNSL
  • Primary CNS lymphoma

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients'. Together they form a unique fingerprint.

  • Cite this

    Karantanis, D., O'Neill, B. P., Subramaniam, R. M., Witte, R. J., Mullan, B. P., Nathan, M. A., Lowe, V. J., Peller, P. J., & Wiseman, G. A. (2007). F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients. Nuclear medicine communications, 28(11), 834-841. https://doi.org/10.1097/MNM.0b013e328264ae7f